INTRODUCTION
The estimation of genetic risks of radiation exposures of human populations has been an on-going scientific activity for over 50 years. The fact that the genetic material of the germ cells could be damaged by radiation resulting in mutations in the descendants was discovered in Drosophila research already in the late 1920s. In the aftermath of the detonation of atomic bombs over Hiroshima and Nagasaki in 1945, concern over genetic risks to the children of those exposed to radiation assumed an unprecedented seriousness. Several programs of research were initiated among which were (a) epidemiological studies of A-bomb survivors for cancers, and their children for adverse hereditary effects; these studies conducted by the Radiation Effects Research Foundation (RERF) still continue and (b) animal experiments, chiefly with the mouse, on radiation-induced mutations; these were carried out in several centres in the USA, England, Germany and Japan.
The principal questions that come to mind when one talks about genetic risks are: will the children of exposed people be affected by some adverse health effects attributable to mutations induced in parental germ cells? What kind of adverse effects? Will the increase in the frequency of affected children be trivial, small or substantial? How do we express these effects quantitatively? On the last question, early on (i.e., in the 1950s and 1960s) scientific committees involved in genetic risk estimation considered it appropriate to express genetic risks in terms of inducible genetic diseases (just as cancer risks are expressed in terms of the various types of cancers) and this concept still remains a central one in risk estimation. However, at the time the various studies were started, there were no human data on radiation-induced germ cell mutations, let alone radiation-induced genetic disease. There was, therefore, a compelling need to develop indirect methods for predicting genetic risks using the mouse data on radiation-induced mutations. One such method is what is referred to as the 'doubling dose method' (see ref.
1 for a discussion of the method, its evolution and current status). The points of importance here are the following: the method uses (a) human data on naturally-occurring genetic diseases as a framework; (b) mouse data on radiation-induced germ-cell mutations and (c) the theory of equilibrium between mutation and selection (which population geneticists use to describe the dynamics of mutant genes in populations) to express risks in terms of inducible genetic diseases.
CURRENT ESTIMATES OF GENETIC RISKS
The most recent estimates of genetic risks are those published in 2001 by UNSCEAR 2) and these are summarised in Table 1 . The estimates pertain to the first generation progeny of an irradiated population and are expressed in terms of inducible genetic diseases of different types. The predicted total risk is small, being about 3,000 to 4,700 cases per million progeny per Gy of low LET, low dose radiation, compared to the baseline risk of about 738,000 cases per million, i.e., about 0.4 to 0.6% of the baseline risk per Gy.
It should be realized that so far, no radiation-induced human germ cell mutations or genetic diseases have been found. In the 1990s, several advances in the molecular biology of human genetic diseases were made and a sizeable amount of data on molecular analyses of radiation-induced mutations in experimental systems also became available. These advances permitted a re-examination of the concept of radiation-inducible genetic disease in the late 1990s. Two major concepts emerged: (a) most radiation-induced mutations are DNA deletions, often of multiple genes; however, only a proportion of these is likely to be compatible with live births and (b) the principal phenotypes of viability-compatible deletions are more likely to be multi-system developmental abnormalities -which we call congenital anomalies -rather than single-gene diseases. 3) In considering how to move forward in the field using the above concepts as starting points, we were guided by the view that knowledge of mechanisms underlying the origin of deletions would be instructive. Such mechanistic knowledge has emerged from two contemporary areas of research, namely molecular studies of (a) repair of DNA doublestrand breaks (DSBs) in mammalian somatic cells and (b) the origin of deletions in genomic disorders in humans. Although approached from different perspectives, DSBs and the mechanisms of repair of these lesions constitute the common themes for both these fields of research. 
REPAIR OF NATURALLY-OCCURRING AND RADIATION-INDUCED DSBs IN MAMMALIAN SOMATIC CELLS
Of the various types of DNA lesions induced by ionizing radiation, DSBs are considered to be the most relevant from the standpoint of biological effects i.e., the lack of repair or misrepair of DSBs underlie the effects such as cell-killing, mutations and chromosomal aberrations. DSBs also arise endogenously during DNA replication or as initiators of programmed cellular processes such as V(D)J recombination and meiotic exchange. Mammalian cells have considerable ability to repair naturally-occurring and induced DSBs. The DSB repair pathways that have been extensively studied in yeast and mammalian somatic cells can be broadly classified under two headings: homologous recombination repair (HRR) and non-homologous end-joining (NHEJ). A third process, called single-strand annealing (SSA) is considered as a variant of HRR (see refs.4-10 for reviews).
Homologous recombination repair (HRR)
In classical genetics, the term homologous recombination (HR) is used to describe the process through which reciprocal exchange of genetic material between homologous chromosomes occurs in sexual organisms. In this process, which occurs in prophase I of meiosis, the homologous chromosomes (i.e., the paternal and maternal chromosomes) condense, pair and exchange genetic material. The pairing between homologues is precise i.e., it occurs between alleles located at identical positions on the paternal and maternal chromosomes of a given pair, and because of the reciprocal exchange of genetic material, the daughter chromosomes that result from HR do not sustain any loss or gain of genetic material. HR is now understood at the molecular level as a process that is initiated by programmed occurrence of DNA DSBs in meiosis and their repair by recombination with homologous sequences on a non-sister chromatid (hence the term, 'homologous recombination repair'(HRR).
Current knowledge about HRR and models of how this process operates in irradiated somatic cells derive from stud- ies of meiotic recombination in the yeast Saccharomyces cervisiae. 11, 12) The basic model of HRR is shown in Fig. 1 . Following the induction of a DSB, both the 5'-ends are resected by the action of a specific nuclease to yield 3'-single-stranded ends. Subsequently, one of the 3'-ends invades an intact homologous duplex and generates a D-loop structure. The invading 3'-end is then used to initiate DNA synthesis using the intact homologous duplex as a template. After the enlargement of the D-loop, the other 3'-end can also prime for DNA synthesis. Resolution of the joint intermediary products of the reaction and ligation of the ends, which require the activity of a number of enzymes, results in the formation of two possible cross-over and two noncross-over products. The important point with respect to HRR is that an intact DNA duplex serves as the template for repair and therefore the repair process is generally error-free. Genes of the ' RAD52 epistasis group' are central to both HR in meiotic cells and DSB repair by HRR in somatic cells. Additionally, both BRCA1 and BRCA2 are required for normal levels of HR and DSB repair. 13, 14) Single-strand annealing (SSA) SSA is considered to be a variant of HRR in that it operates when the DSB occurs between two flanking homologous repeat sequences and was first observed in mammalian cells 15) and subsequently in Xenopus laevis oocytes 16, 17) and in yeast. 18) SSA is initiated by extensive 5'-3' resection of the DSB ends until substantial regions of homology (~ 400 bp) flanking the break are exposed on long single-stranded 3'-tails. Repair is completed by removal of non-homologous ends and subsequent ligation (see Fig. 1 ). During this process, the loss of one of the two direct repeats and the intervening DNA occurs and so it is an error-prone DSB repair process. In yeast, unlike HRR, SSA is dependent on RAD52, but does not require RAD51 protein (reviewed in ref. 8) .
Non-homologous end-joining (NHEJ)
In contrast to HRR, NHEJ brings about the ligation of the two DNA DSBs without the requirement of sequence identity between the two recombining ends (see Fig. 1 ). The NHEJ pathway is required to process the DSB intermediates generated during the natural process of V(D) J recombination and is also the one that is used to repair radiationinduced DSBs when no undamaged homologous DNA molecule is available. Most DSBs induced by ionizing radiation are complex and therefore, cannot be directly ligated; some limited processing and/or polymerization must take place before NHEJ can ensue. Consequently small sequence deletions, additions etc., are introduced during the process. NHEJ, at least in the case of radiation-induced DSBs, is therefore error-prone.
Although there are several proteins that participate in the overall recognition and response to DSBs, in the context of NHEJ, six proteins are currently known to be directly required for catalysing repair. Three of these are components of the DNA-dependent protein kinase (DNA-PK) which include Ku70 and Ku80 (the latter also called Ku86) which together form a DNA end-binding complex (Ku) and the DNA-PK cs catalytic subunit. Of the remaining three, DNA ligase IV and XRCC4 function as a complex to ligate DNA ends and Artemis which in combination with DNA-PK cs acts as an endonuclease at both the 5'-and 3'-overhangs. The genes that encode these proteins are the following: XRCC7 (DNA-PK cs ); XRCC6 and XRCC5 (the Ku70/Ku86 heterodimer); LIGIV (DNA ligase IV) and XRCC4 (XRCC4) (reviewed in refs. [5] [6] [7] [8] .
Relative importance of HRR, SSA and NHEJ pathways in mammalian cells
In mammals, the relative importance of the different DSB repair pathways varies depending on the developmental stage [19] [20] [21] and in somatic cells, the cell-cycle phase. The current consensus view is that while the pathways are not mutually exclusive and a pure separation of NHEJ and HRR would be an oversimplification, NHEJ is the predominant pathway in G 0 /G 1 and early S-phases of the cell cycle while HRR predominates over other pathways during late-S and G 2 phases. [22] [23] [24] The role of SSA is presumably similar to that of HRR.
MECHANISMS OF ORIGIN OF LARGE DELE-TIONS CAUSING HUMAN GENETIC DISORDERS

Repetitive sequences
All the mechanisms that have been proposed to explain the origin of deletions or other rearrangements underlying human genetic diseases (and in genomic disorders which constitute a subset of genetic diseases that is associated with large deletions and/or duplications) are related to genomic architectural features, namely, the presence of repetitive sequences of one kind or another. The different types of repetitive sequences comprise at least 50% the human genome and include interspersed repeats ( e.g ., SINEs and LINEs), processed pseudogenes, simple sequence repeats, blocks of tandemly repeated sequences present at the centromeres, telomeres and the short arms of acrocentric chromosomes, ribosomal gene clusters and segmental duplications. 25, 26) Here we focus on segmental duplications. Also called duplicons, these are duplications of large segments of genomic DNA ( ≥ 90% sequence identity) that range in size from 1 to 400 kb with a genome-wide content of about 5%. 26, 27) These can be divided into two groups: intra-chromosomal duplicons also called low copy repeats (LCRs) and inter-chromosomal or transchromosomal duplicons. [28] [29] [30] LCRs can contain genes, gene fragments, pseudogenes, microsatellites, endogenous retroviral sequences etc. The transchromosomal duplicons map to multiple chromosomes, in particular to the pericentromeric and subtelomeric regions. 
Non-allelic homologous recombination
The relevance of LCRs in the present context stems from the observations that these flank many genomic regions susceptible to large deletions; the latter have been shown to result from LCR misalignment and the occurrence of unequal crossing-over or non-allelic homologous recombination (NAHR) in meiosis. Lupski 31) coined the term 'genomic disorders' for the genetic diseases which arise by this mechanism. So far about 30 genomic disorders are known and someexamples are given in Table 2 . Catalogues of several hundred segmental duplications which can potentially lead to genomic rearrangements have been published.
32,33)
Models
The LCR/NAHR-based models that have been proposed to explain the origin of deletions and other rearrangements ( e.g ., duplications, inversions) include those between homologous chromosomes ( inter-chromosomal), between sister chromatids ( intra -chromosomal) and within single chromatids ( intra -chromatid) (reviewed in ref. 34) . Figure 2 taken from the paper of Ji et al . 28) depicts some of the main possibilities and the predicted products. The overall message of Fig. 2 is that, depending on which mechanism operates and the orientation of the LCRs, NAHR can result in deletions, duplications or inversions. Not shown in the Fig. is the possibility of NAHR between transchromosomal duplicons which will result in translocations.
At the molecular level, the steps hypothesised for NAHR are presumed to be the same as those for HRR: the occurrence of a DSB to initiate the process, interaction of sequence substrates in LCR for recombination and resolution of recombination intermediates with the formation of novel recombination products. 35, 26) Studies of breakpoints of the rearrangements originating via the LCR/NAHR mechanism support the view that despite large stretches of sequence identity, 'hotspots' exist for the majority of crossovers that occur within LCRs (reviewed in ref. 37 ).
EXTENSION OF CONCEPTS FROM THE PRE-CEDING SECTIONS TO GERM CELL STAGES AND TO ENDPOINTS OF RELEVANCE IN RISK ESTIMATION
Germ cell stages
The germ cell stages of importance from the standpoint of genetic risks of radiation are the stem cell spermatogonia in males and immature oocytes in females. The kinetics of spermatogonial stem cell proliferation and differentiation in the mouse has been reviewed by de Rooij and Grootehoed 38) and de Rooij and Russell. 39) The findings that are pertinent in the present context are the following:
The proliferative activity of the stem cells follows a cyclic pattern marked by periods of quiescence (cells in G 0 ) fol- lowed by active mitosis. The estimated cell cycle time is about 70 to 100 h and the majority of the cells will be in G 0 / G 1 while a minority, in S and G 2 phases. The cell cycle times for human spermatogonia are not known, but judging from the observations that these cells divide only once per germinal epithelial cycle of 16 days, it can be assumed that the cell cycle duration may be of the order of about 16 days. 40, 41) Here too, most of the stem cells will be in G 0 /G 1 .
In the mouse, sensitivity to radiation-induced killing differs markedly between spermatogonial stem cells: those in G 0/ G 1 being more sensitive to killing than those in the proliferative mode (D 0 estimates of 1 Gy versus 2.4 Gy for Xrays) suggesting that at high doses of the order of a few Gy (used in most mutation experiments), proliferating stem cells selectively survive. [42] [43] [44] The situation in human spermatogonial cells in this regard is not known.
Female mammals are born with a finite number of oocytes formed already during embryonic development. These socalled primordial oocytes are surrounded by a single layer of follicular cells. With maturation, the oocytes grow and multi-layered follicles are formed. In the oocytes, irrespective of the stage of follicular growth, the sequence of nuclear changes comprising meiosis is arrested at the diplotene stage and lasts until the time of ovulation. Diplotene is the stage at which the paired chromosomal bivalents (each made of two sister chromatids) held together by chiasmata begin desynapsis.
45)
Hypothesised relationships between cell cycle phase of spermatogonial stem cells (or meiotic stage in oocytes) at the time of irradiation, DSB repair processes and biological endpoints
In extending the concepts derived from DSB repair studies in somatic cells (i.e., the roles of HRR, SSA and NHEJ and their relative importance in the different cell cycle phases) and the origin of human genomic disorders (i.e., the role of NAHR between region-specific duplicons in generating deletions, duplications and other changes), to germ cells and the biological endpoints of relevance, the following specific assumptions are used: (a) the DSB repair processes identified in somatic cells also function in germ cells and in similar ways and (b) in the context of DSB repair, NAHR can be considered as an error-prone form of HRR occurring between misaligned repetitive sequences and (c) when, as a result of induced DSBs, the cellular machinery stimulates HRR in germ cells, NAHR also occurs.
As discussed earlier in this section, in both humans and mice, most of the spermatogonial stem cells are expected to be in G 0 /G 1 phase of the cell cycle. When males are irradiated, one can assume that the DSBs induced in spermatogonial stem cells will be processed predominantly by NHEJ and to a smaller extent by HRR/NAHR and SSA. In females, the oocytes are in the diplotene stage at the time of irradiation. Consequently, DSB repair in irradiated oocytes is likely to occur predominantly through HRR, NAHR and SSA; the role of NHEJ is probably minor. Taking the above into account, one can postulate certain relationships between DSB repair processes and the biological endpoints (deletions, duplications, inversions and translocations) and these are shown in Table 3 . As will be clear, in spermatogonial cells, the induction of: (a) large deletions and reciprocal translocations can be explained by NAHR, SSA and NHEJ; (b) large duplications is consistent with the NAHR mechanism but not with NHEJ or SSA and (c) inversions is consistent with both NAHR and NHEJ, but not with SSA. In oocytes, the origin of deletions, duplications, translocations and inversions can all be explained by NAHR. A small proportion of deletions and translocations can arise via SSA, but duplications and inversions are not likely to arise via SSA. NHEJ probably plays a minor role.
Potential relevance for risk estimation
Here we focus on deletions, the predominant type of damage that is considered to be of relevance for risks. On the premise that the deletions in irradiated spermatogonial stem cells arise as a result of DSBs induced in the different cell cycle phases and the repair processes that handle them, at low doses, one can assume that most deletions will originate in cells irradiated in the G 0 /G 1 phases (repair by NHEJ) while a small proportion will come from cells irradiated in the S and G 2 phases (repair by NAHR and SSA). In the case of oocytes, the assumption is that most of the induced deletions will arise as a result of NAHR between sister chromatids with probably smaller contributions from SSA-and NHEJ-mediated repair processes. Note that, with the stated assumptions, the above inferences are valid at the time DSBs are induced and repaired resulting in deletions; the deletions recoverable in live births would be those that have survived the constraints imposed by their effects during the remaining stages of spermatogenesis in males, or during growth and maturation of immature oocytes in females (the latter dependent on the proportion of oocytes carrying deletions recruited to the pool of growing oocytes) and which are compatible with viability in heterozygotes.
If the hypothesis that LCR-mediated NAHR may be a major mechanism of DSB repair that can generate deletions in irradiated human oocytes and that this mechanism may account for at least a proportion of deletions induced in human spermatogonial stem cells is valid, then one can consider the LCR maps of chromosomes as P rimary S equencebased D eletion P redisposition M aps (PSDPMs). The PSDPMs can serve as initial 'entry points' into the genome. The question to be asked is the following: given the PSDPMs and other genomic resources ( e.g ., structural and transcriptome maps of the mouse and human genomes), how does one use them to predict regions of the human genome that are susceptible to radiation-induced deletions?
The general principles of the strategy envisaged are the following: (a) superimpose the LCR maps on transcriptome maps and make a preliminary assessment of where in the genome, LCR-mediated deletions/duplications are likely to occur spontaneously, the potential viability of the deletions and their phenotypes; (b) in computer simulation experiments, 'induce' DSBs at random in cellular DNA in a dosedependent fashion and examine what proportion of the For the NHEJ and SSA mechanisms in the origin of radiation-induced deletions, at present, there does not appear to be any simple way to define 'entry points' into the genome for using the kind of approaches that is envisaged for NAHR.
CONCLUSIONS AND PERSPECTIVES
In this paper, mechanistic concepts that have emerged from studies of DSB repair in mammalian somatic cells and from studies of the LCR/NAHR-mediated origin of deletions in human genomic disorders were extended to radiationinducible deletions in human germ cells. On the basis of this extension, it is hypothesised that at low radiation doses (a) NHEJ is likely to be the principal mechanism of DSB repair that generates deletions in spermatogonial stem cells and (b) LCR-mediated NAHR may be the more important mechanism that underlies the origin of deletions in oocytes. Should this hypothesis be true, it is possible to develop a LCR/ NAHR-based model for predicting where in the genome radiation-induced deletions may occur. The application of the model would be particularly relevant in the context of assessing genetic risks of radiation of human females because this aspect has remained unresolved over the past five decades of genetic risk estimation.
To be sure, we are not talking of 'low hanging fruits'; several 'proof-of-principle' studies need to be carried out in humans and mice to validate the role of the LCR/NAHR mechanism in the origin of deletions and other rearrangements before one can seriously embark on modelling studies using the genome as the starting point for radiation damagerelated inquiries. Some of these are listed below.
For instance, although several hundred LCRs have been mapped to human chromosomes, so far only about 30 genomic disorders have been found. One possible reason for this discrepancy may be that a lot more deletions (and duplications) are indeed generated, but most of them are eliminated because of inviability. This possibility can be examined by molecular analysis of material derived from spontaneous abortions. Second, chromosome maps of deletions and duplications associated with congenital malformations are available. 46, 47) It would be instructive to superimpose LCR maps on these and examine the level of correspondence between the two. In the mouse, molecular analysis of mutants carrying deletions and duplications recovered from spermatogonial and oocyte radiation experiments (especially the analysis of the breakpoints) would seem worthwhile.
The main focus of this paper has been on LCR-mediated NAHR in the origin of radiation-induced large multigene deletions. However, radiation also induces small deletions. The origin of single gene deletions underlying some human Mendelian diseases is known to be mediated by NAHR between interspersed repeats such as the Alu sequences (reviewed in ref. 48) . It is conceivable that these sequences may also play a role in the origin of small radiation-induced deletions. The framework for modelling their origin in the radiation context is basically similar to that discussed for LCRs.
Knowledge of the human genome has been advancing rapidly and it is becoming possible to 'interrogate' the genome, also for genetic effects of radiation. Progress in estimating genetic risks of radiation in the 21 st century will be heavily dependent on the active involvement of mouse and human genome specialists besides human geneticists, population geneticists, mathematicians, experimental geneticists and epidemiologists whose combined efforts have thus far contributed to the growth and development of this field.
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